Venezuela will receive 6.2 million doses of COVID-19 vaccines through the global COVAX initiative in the coming days, Reuters news agency reported on Monday.
President Nicolas Maduro had reportedly given COVAX an "ultimatum" to send the doses or return the funds Venezuela has already paid.
This announcement comes after the GAVI alliance, which co-runs the COVAX facility along with the World Health Organisation (WHO), said in early July 2021 that COVAX had received payments from Venezuela after the country's officials said some payments were blocked by a bank due to US sanctions.
According to the Pan-American Health Organisation (PAHO), the regional arm of the WHO, Venezuela will receive doses of Chinese pharmaceutical company Sinopharm (HKG:1099) and biopharmaceutical Sinovac Biotech Ltd(Nasdaq:SVA) vaccines through the initiative.
The country has so far been administering Sinopharm, Russia's Sputnik-V and Cuba's Abdala COVID-19 vaccines, Reuters added.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses